Starting from the growth hormone market of tens of billions, how deep is the "increasing needle"? _Sina Finance_Sina.com Post date May 13, 2022 — 23:15 Post Lock Read More Hangyang Co., Ltd. (002430): Proposed change of independent director- CFi.CN China Financial Network Post date May 13, 2022 — 18:47 Post Lock Read More Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval. Post date May 12, 2022 — 20:59 Post Lock Read More Ou Weiting’s domestic online debut, JD.com Pharmacy and Yifan Pharmaceutical to create a digital service benchmark – yqqlm Post date May 9, 2022 — 10:46 Post Lock Read More Yifan Pharmaceutical: Personnel changes in executives Post date May 7, 2022 — 00:50 Post Lock Read More Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hangyang Co., Ltd. (002430): Proposed change of independent director- CFi.CN China Financial Network Post date May 13, 2022 — 18:47 Post Lock Read More Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval. Post date May 12, 2022 — 20:59 Post Lock Read More Ou Weiting’s domestic online debut, JD.com Pharmacy and Yifan Pharmaceutical to create a digital service benchmark – yqqlm Post date May 9, 2022 — 10:46 Post Lock Read More Yifan Pharmaceutical: Personnel changes in executives Post date May 7, 2022 — 00:50 Post Lock Read More Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval. Post date May 12, 2022 — 20:59 Post Lock Read More Ou Weiting’s domestic online debut, JD.com Pharmacy and Yifan Pharmaceutical to create a digital service benchmark – yqqlm Post date May 9, 2022 — 10:46 Post Lock Read More Yifan Pharmaceutical: Personnel changes in executives Post date May 7, 2022 — 00:50 Post Lock Read More Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ou Weiting’s domestic online debut, JD.com Pharmacy and Yifan Pharmaceutical to create a digital service benchmark – yqqlm Post date May 9, 2022 — 10:46 Post Lock Read More Yifan Pharmaceutical: Personnel changes in executives Post date May 7, 2022 — 00:50 Post Lock Read More Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharmaceutical: Personnel changes in executives Post date May 7, 2022 — 00:50 Post Lock Read More Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Industry Observations Post date May 1, 2022 — 23:10 Post Lock Read More Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year. Post date May 1, 2022 — 02:07 Post Lock Read More Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency" Post date April 27, 2022 — 11:21 Post Lock Read More Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:40 Post Lock Read More Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific Post date April 27, 2022 — 07:32 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific Post date April 27, 2022 — 07:31 Post Lock Read More Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm Post date April 26, 2022 — 19:51 Post Lock Read More What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment Post date April 23, 2022 — 18:03 Post Lock Read More Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm Post date April 23, 2022 — 13:06 Post Lock Read More Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network Post date April 22, 2022 — 07:26 Post Lock Read More Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific Post date April 22, 2022 — 07:25 Post Lock Read More Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules. Post date April 21, 2022 — 06:59 Post Lock Read More Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic Post date April 21, 2022 — 06:58 Post Lock Read More Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present. Post date April 21, 2022 — 06:57 Post Lock Read More Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly Post date April 21, 2022 — 06:57 Post Lock Read More
Caishen.CoCaishen.Co